Anti-CD20 monoclonal antibody therapy in refractory immune thrombocytopenic purpura

Haematologica

Volumn 87, Issue 2, 2002, Pages 215-216

  Delgado, Julio ^a   Bustos, Jesús G ^a   Jimenez Yuste, Victor ^a   Hernandez Navarro, Fernando ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Immune thrombocytopenic purpura; Refractory; Rituximab

Indexed keywords

IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD 20; RITUXIMAB; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MEGAKARYOCYTE; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; AUTOIMMUNE DISEASES; DRUG EVALUATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOTHERAPY; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; REMISSION INDUCTION; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 0036175257     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura
2. Long-term follow-up of idiopathic thrombocytopenic purpura in 310 patients
3. Therapy for adults with refractory chronic immune thrombocytopenic purpura
4. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura
5. A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia
6. An evaluation of a solid phase red cell adherence test for detecting platelet-associated IgG in immune thrombocytopenia
7. Platelet antibody testing in idiopathic thrombocytopenic purpura
8. Platelet immunoglobulin G: Its significance for the evaluation of thrombocytopenia and for understanding the origin of α-granule proteins